🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — looking for input Page 3

Mounjaro KwikPen vs vial — looking for input

tony_orlando Sat, Oct 19, 2024 at 1:14 AM 33 replies 2,392 viewsPage 3 of 7
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Oct 21, 2024 at 7:41 PM#11
LindaRN_retired said:
SURMOUNT-1 landed around 20.9% mean weight loss at 15mg over 72 weeks, against roughly 15% for semaglutide 2.4mg in STEP 1.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

Last edited: Oct 21, 2024 at 9:41 PM
40 13sarah.morrison, NeuroNate, JessicaH_TX and 37 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Oct 22, 2024 at 7:33 AM#12

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Last edited: Oct 22, 2024 at 11:33 AM
41 14wanda_boise, NurseAsh_DET, BenResearch_OR and 38 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Oct 22, 2024 at 7:25 PM#13
carl_compliance said:
It helps to say which part of this you are uncertain about.

This is where I part company with the consensus forming above. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

42 15tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Oct 23, 2024 at 7:17 AM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Oct 23, 2024 at 11:17 AM
43 16MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 40 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 23, 2024 at 7:10 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out.

44 17PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 41 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register